Yes, Nausea is Associated with Parkinson's Disease
Nausea is a well-recognized gastrointestinal symptom directly associated with Parkinson's disease itself, occurring both as a manifestation of the disease and as a side effect of antiparkinsonian medications.
Nausea as a Disease Manifestation
Nausea is one of the core gastrointestinal symptoms that occurs in Parkinson's disease patients, independent of treatment. Multiple studies have validated nausea as a symptom truly associated with PD 1. This occurs due to:
- Gastrointestinal dysmotility: PD affects the enteric nervous system, leading to gastroparesis which produces nausea along with other symptoms 2
- Autonomic dysfunction: Dysautonomic symptoms including nausea appear early in the disease process, often before motor symptoms become prominent 3
- Disease pathology: The Braak staging model suggests PD pathology begins in the gut's autonomic innervation before affecting the substantia nigra, explaining why GI symptoms like nausea can precede motor manifestations 4
Research demonstrates that nausea, along with abnormal salivation, dysphagia, constipation, and defecatory dysfunction, represents one of the five core GI symptoms more common in PD patients compared to controls 1.
Nausea from Antiparkinsonian Medications
The medications used to treat PD significantly contribute to nausea, making it a dual problem:
The ESPEN guideline explicitly states that drugs prescribed for PD have side effects that influence nutritional status, including nausea, vomiting, abdominal pain, dyspepsia, constipation, weight decrease, dry mouth, diarrhea, anorexia and GI disorders 5. These medication-related side effects have been reported by patients as contributing to weight loss and changes in food intake 5.
Key medication considerations:
- Levodopa: Associated with nausea as a common side effect, particularly at treatment initiation and with dose escalation 5
- Dopamine agonists: Also cause nausea and other GI symptoms 5
- The relationship is dose-dependent, with higher levodopa equivalent doses correlating with increased GI side effects 5
Clinical Implications
Monitoring Requirements
PD patients should undergo regular monitoring of nutritional status throughout the disease course, with particular attention to:
- Changes in body weight
- GI symptom burden including nausea
- Side effects of antiparkinsonian medications 5
Treatment Considerations for Gastroparesis-Related Nausea
When PD patients develop gastroparesis with significant nausea, the 2025 AGA gastroparesis guideline provides specific guidance:
Domperidone may be especially helpful for patients with gastroparesis who have neurologic movement disorders, such as Parkinson's disease 6. This is because:
- It doesn't readily cross the blood-brain barrier
- It has fewer central nervous system side effects than metoclopramide
- Metoclopramide carries a black box warning for tardive dyskinesia and can worsen motor symptoms in PD patients 6
Common Pitfall
Do not assume nausea in a PD patient is solely medication-related. The disease itself causes gastroparesis and autonomic dysfunction that produce nausea independent of treatment. Both factors often coexist and require comprehensive assessment 7, 2.
The presence of nausea should prompt evaluation of both disease-related GI dysfunction and medication side effects, with management tailored to address both contributors when present.